Galaxy Surfactants Limited

NSE:GALAXYSURF.NS

3164.8 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q4
Revenue 9,740.69,2909,404.99,831.29,417.79,744.710,802.612,316.311,588.810,199.59,290.98,7738,263.87,448.16,7477,186.86,071.66,235.56,258.96,488.26,650.26,508.36,794.76,853.37,161.96,435.65,978.76,101.15,823.76,021.4
Cost of Revenue 7,504.87,241.16,415.46,738.16,3676,587.77,390.99,004.68,017.67,251.16,740.66,444.75,642.35,132.54,200.44,577.43,995.34,317.84,216.44,330.14,428.44,7834,7714,833.25,214.44,624.94,265.74,401.44,219.14,419.4
Gross Profit 2,235.82,048.92,989.53,093.13,050.73,1573,411.73,311.73,571.22,948.42,550.32,328.32,621.52,315.62,546.62,609.42,076.31,917.72,042.52,158.12,221.81,725.32,023.72,020.11,947.51,810.71,7131,699.71,604.61,602
Gross Profit Ratio 0.230.2210.3180.3150.3240.3240.3160.2690.3080.2890.2740.2650.3170.3110.3770.3630.3420.3080.3260.3330.3340.2650.2980.2950.2720.2810.2870.2790.2760.266
Reseach & Development Expenses 0308.7000275000293.4000269.2000269000261.1000260.70000
General & Administrative Expenses 000000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000000
SG&A 1,260.61,294.51,188.61,198.3713.21,1771,271.41,367.5618.6700.8515.8478995.11,100490.6497.9462.9590.8432427.5456.4533408417.6382.6493.5350.3366.9366.4295.6
Other Expenses 54239.163.826.824.970.337.410.8-20-14.617.650.445.2-37.330.445.76.7-19.133.61312.587.910.318.9-17.215.725.627.530.50
Operating Expenses 1,260.61,294.52,115.92,090.82,056.92,0372,086.72,199.62,280.31,674.31,963.81,800.61,7051,309.31,520.41,561.21,3361,046.41,385.41,431.41,409.7901.61,328.41,279.21,185.71,235.11,080.61,082.11,036.4983.3
Operating Income 975.2754.4937.41,029.1993.81,190.31,362.41,122.91,290.91,265.8586.5527.7916.5942.81,056.61,048.2740.3871.3657.1726.7812.1823.7695.3740.9761.8575.6632.4617.6568.2558.9
Operating Income Ratio 0.10.0810.10.1050.1060.1220.1260.0910.1110.1240.0630.060.1110.1270.1570.1460.1220.140.1050.1120.1220.1270.1020.1080.1060.0890.1060.1010.0980.093
Total Other Income Expenses Net 14.2185.2-59-54.1-32.1-61.3-55.5-56.3-63.9-22.2-10.713.416.1-12.6-24.413.7-41.4-55.5-24.8-51.3-47.2-43.7-60.8-54.2-94.5-50.8-50.6-59.1-45.715.1
Income Before Tax 989.4939.6878.4975961.71,1291,306.91,066.61,2271,243.6575.8541.1932.6930.21,032.21,061.9698.9815.8632.3675.4764.9780634.5686.7667.3524.8581.8558.5522.5574
Income Before Tax Ratio 0.1020.1010.0930.0990.1020.1160.1210.0870.1060.1220.0620.0620.1130.1250.1530.1480.1150.1310.1010.1040.1150.120.0930.10.0930.0820.0970.0920.090.095
Income Tax Expense 192.2164.6164.7200.8209.9223.7244.8227.9223.3259.6119.6121.7164.4143.4179.9244.5134187.8152.44.7239.4209216223.5210.2124.5168.6150.3164141.3
Net Income 797.2775713.7774.2751.8905.31,062.1838.71,003.7984456.2419.4768.2786.8852.3817.4564.9628479.9670.7525.5571418.5463.2457.1400.3413.2408.2358.5432.7
Net Income Ratio 0.0820.0830.0760.0790.080.0930.0980.0680.0870.0960.0490.0480.0930.1060.1260.1140.0930.1010.0770.1030.0790.0880.0620.0680.0640.0620.0690.0670.0620.072
EPS 22.4921.8620.1321.8421.225.5329.9623.6628.3127.7612.8611.8321.6722.1924.0423.0615.9317.7213.5418.9214.8216.1111.813.0712.8911.2911.6611.5110.1112.2
EPS Diluted 22.4921.8620.1321.8421.225.5329.9623.6528.3127.7612.8611.8321.6722.1924.0423.0615.9317.7213.5418.9214.8216.1111.813.0712.8911.2911.6611.5110.1112.2
EBITDA 1,240.81,016.61,188.71,275.71,256.71,415.41,5781,327.71,460.21,437.8781.5759.11,130.11,110.31,225.11,260.9911.31,032.4855893.3973.2994.2834.6887.9870.4714779.9766.2718.3675.65
EBITDA Ratio 0.1270.1090.1260.130.1330.1450.1460.1080.1260.1410.0840.0870.1370.1490.1820.1750.150.1660.1370.1380.1460.1530.1230.130.1220.1110.130.1260.1230.112